Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.94−0.07 (-6.72%)
Close on Nov 18, 2026Market cap $164.18MP/E –Yield –
Palisade Bio market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Palisade Bio's market cap was $203.11M on Nov 11, 2026, against $19.24M a year earlier. Over the last 5 years it ranged from $1.63M to $354.93M, with a median of $5.76M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $203.11M | +847.8% |
| 2025 | Dec 31, 2025 | $21.43M | +983.7% |
| 2024 | Dec 31, 2024 | $1.98M | -63.6% |
| 2023 | Dec 29, 2023 | $5.43M | -32.2% |
| 2022 | Dec 30, 2022 | $8.02M | -52.3% |
| 2021 | Dec 31, 2021 | $16.81M | -81.6% |
| 2020 | Dec 31, 2020 | $91.32M | +445.5% |
| 2019 | Dec 31, 2019 | $16.74M | -41.4% |
| 2018 | Dec 31, 2018 | $28.57M | -81.7% |
| 2017 | Dec 29, 2017 | $156.34M | -17.0% |
| 2016 | Dec 30, 2016 | $188.40M | -66.8% |
| 2015 | Dec 31, 2015 | $567.60M | -60.1% |
| 2014 | Dec 31, 2014 | $1.42B | +6.3% |
| 2013 | Dec 31, 2013 | $1.34B | +200.6% |
| 2012 | Dec 31, 2012 | $445.08M | +56.9% |
| 2011 | Dec 30, 2011 | $283.73M | – |
See a number that looks wrong?